These studies showed that 4 genes (PDE7B, ELMO1, UPK1A and GRIK2) out of 22 validated genes, which were upregulated in BTSH, indicated good prognosis in HER2 positive breast cancer patients, either individually or working as a gene expression signature (Fig. 7). The gene discussed is GRIK2; the disease is breast carcinoma.